---
phase: 11-supplement-and-drug-database
verified: 2026-06-05T00:00:00Z
status: human_needed
score: 3/4 must-haves verified
overrides_applied: 0
human_verification:
  - test: "Interaction checker severity grouping — visual UX judgment"
    expected: "Results visually grouped by severity level (red/dangerous flags first, then yellow/moderate, then green/beneficial) in a way a user would describe as 'grouped'"
    why_human: "The implementation sorts by severity and uses color-coded badges (SEVERITY_CONFIG: high=danger/red, moderate=warning/yellow, low=primaryLight/blue-green, beneficial=primaryLight/green). Results display as a sorted flat list with color indicators — not explicit section headers like 'HIGH RISK (3)', 'MODERATE (2)', 'MONITOR (2)'. Whether sorted+color-coded meets 'grouped by severity' requires visual UX judgment on the actual rendered screen."
---

# Phase 11: Supplement & Drug Database Verification Report

**Phase Goal:** The protocol screen surfaces 8 evidence-graded longevity supplements and 5 drug classes with mechanism summaries, and the interaction checker evaluates the user's entire current stack with color-coded flags and plain-language recommendations
**Verified:** 2026-06-05
**Status:** human_needed
**Re-verification:** No — initial verification

---

## Goal Achievement

### Observable Truths

| # | Truth | Status | Evidence |
|---|-------|--------|----------|
| 1 | User browsing supplement library sees all 8 longevity supplements with dose, timing, evidence grade, and a one-line longevity relevance summary | VERIFIED | All 8 present: NMN (line 30), NR (line 45), Urolithin A (line 772), Spermidine (line 479), Fisetin (line 464), Quercetin (line 268), Rapamycin/rapamycin_rx (line 748), Metformin/metformin_rx (line 732). SupplementLibrarySection renders evidence grade badge, `name`, `shortDescription` (one-line summary), dose in expanded detail. All entries have non-empty `shortDescription` and `evidenceGrade`. |
| 2 | User browsing drug database sees all 5 drug classes (Ibuprofen, Aspirin, Statins, Levothyroxine, Metformin) with same field structure | VERIFIED | nsaids_class (Ibuprofen/Naproxen), aspirin_class, statins_class, levothyroxine_class, metformin_rx — all 5 present in `prescription_only` category. CAT_ORDER includes `prescription_only` (SupplementLibrarySection.tsx line 12). All 5 have: name, defaultDose, evidenceGrade, shortDescription, timing, mechanismOfAction (except metformin_rx which pre-dates Phase 11). |
| 3 | Interaction checker results are grouped by severity (red/yellow/green flags) with plain-language explanation and specific recommendation per flagged pair | UNCERTAIN | Severity sorting (high→moderate→low→beneficial) and SEVERITY_CONFIG color coding confirmed: `high: Colors.danger`, `moderate: Colors.warning`, `low/beneficial: Colors.primaryLight`. Results render as a sorted flat list with per-card color badges — not explicit section headers per severity group. `body` (plain-language) and `recommendation` ("what to do") both rendered when a card is expanded. Whether sorted+color-coded meets "grouped" requires human visual judgment. |
| 4 | Every interaction flag includes an actionable recommendation — no flag displayed without "what to do" instruction | VERIFIED | Programmatic verification: all 54 INTERACTIONS entries have non-empty `recommendation` field (python3 check: 0 missing). `recommendation` always rendered in expanded `interBody` view (InteractionCheckerScreen.tsx line 308–310). |

**Score:** 3/4 truths verified (1 uncertain, pending human judgment)

---

## Required Artifacts

| Artifact | Expected | Status | Details |
|----------|----------|--------|---------|
| `src/data/supplementTimings.ts` | Extended SupplementInfo interface + ~65 entries | VERIFIED | 71 entries (`grep -c "id:"` = 71). Interface has `mechanismOfAction?`, `longevityRelevance?`, `rxLabel?` at lines 22–24. tsc exit 0. |
| `src/data/biomarkers.ts` | 50+ interaction pairs with recommendation field | VERIFIED | 54 severity entries (`grep -c "severity:"` = 54). All 54 have `recommendation:` field (0 missing). cbd-warfarin entry confirmed (line 1258). |
| `src/components/SupplementLibrarySection.tsx` | Library component with search, categories, inline expand, Add button | VERIFIED | 161 lines. Exports `SupplementLibrarySection`. Search bar, `CAT_ORDER` grouping, collapsible headers, row expansion with "How:" / "Why:" / Dose detail, Add/Remove button calling `onToggle`. 15 `Colors.Beige.*` usages. Zero hardcoded hex values. |
| `src/screens/ProtocolScreen.tsx` | Protocol screen with Library wired below active protocol | VERIFIED | Import at line 18, JSX at lines 731–737, props `addedSupplements={protocol.addedSupplements}` and `onToggle={toggleSupplement}`. libDivider style added. Existing toggleSupplement unchanged. |
| `src/screens/InteractionCheckerScreen.tsx` | Auto-populate + categorized chip sections + 11 SAFE_COMBOS | VERIFIED | useFocusEffect auto-populate (line 82). CATEGORY_TO_DRUG_CLASS (line 29). chipsByCategory useMemo (line 73). Categorized expandable chip render (lines 218–247). 11 SAFE_COMBOS (`grep -c "pair:"` = 11). Old SUPPLEMENTS const removed (0 matches). |

---

## Key Link Verification

| From | To | Via | Status | Details |
|------|----|-----|--------|---------|
| SupplementLibrarySection.onToggle | ProtocolScreen.toggleSupplement | prop callback | WIRED | ProtocolScreen line 736: `onToggle={toggleSupplement}`. SupplementLibrarySection line 92: calls `onToggle(info.name)`. |
| SupplementLibrarySection | SUPPLEMENT_DATABASE | import in component | WIRED | Line 5: `import { SUPPLEMENT_DATABASE, SupplementInfo } from '../data/supplementTimings'` |
| INTERACTIONS entries | InteractionCheckerScreen lookup | `.toLowerCase()` match on `inter.drug` / `inter.supplement` | WIRED | InteractionCheckerScreen lines 176–186: bidirectional substring match. New entries (cbd-warfarin, statins_class entries) use matching drug strings ('Warfarin', 'Statin'). |
| SAFE_COMBOS | InteractionCheckerScreen Safe combos tab | `SAFE_COMBOS.map` in tab === 1 render | WIRED | Lines 367–373: `SAFE_COMBOS.map((c, i) => ...)` renders pair + body. |
| useFocusEffect auto-populate | AsyncStorage @vitalspan_protocol + @vitalspan_user_profile | Promise.all with AsyncStorage.getItem | WIRED | Lines 90–92: `AsyncStorage.getItem('@vitalspan_protocol')` and `AsyncStorage.getItem('@vitalspan_user_profile')`. CATEGORY_TO_DRUG_CLASS resolution at lines 108–115. |
| chip render | SUPPLEMENT_DATABASE | chipsByCategory useMemo | WIRED | Lines 73–80: `chipsByCategory` useMemo groups SUPPLEMENT_DATABASE by category. Lines 218–247: `Array.from(chipsByCategory.entries()).map(...)` renders collapsible chip sections. |

---

## Data-Flow Trace (Level 4)

| Artifact | Data Variable | Source | Produces Real Data | Status |
|----------|--------------|--------|-------------------|--------|
| SupplementLibrarySection.tsx | `filtered` / `grouped` | `SUPPLEMENT_DATABASE` (static import from supplementTimings.ts) | Yes — 71 entries in static TypeScript array | FLOWING |
| InteractionCheckerScreen.tsx | `interactions` | `INTERACTIONS` (static import from biomarkers.ts) cross-matched with `items` | Yes — 54 entries in static array; `items` populated from AsyncStorage on focus | FLOWING |
| InteractionCheckerScreen.tsx | `items` | AsyncStorage `@vitalspan_protocol` + `@vitalspan_user_profile` via useFocusEffect | Real AsyncStorage keys; starts empty if no protocol/profile (correct behavior) | FLOWING |

---

## Behavioral Spot-Checks

Step 7b: SKIPPED (no runnable entry points without Expo / iOS simulator — React Native app requires device/simulator to run)

---

## Probe Execution

Step 7c: N/A — No probe scripts defined for this phase.

---

## Requirements Coverage

| Requirement | Source Plans | Description | Status | Evidence |
|-------------|-------------|-------------|--------|----------|
| SUPP-01 | 11-01, 11-03, 11-05 | Protocol supplement database expanded with 8 longevity supplements; dose, timing, evidence grade, mechanism, longevity relevance | SATISFIED | 71-entry SUPPLEMENT_DATABASE; all 8 named supplements present; SupplementLibrarySection renders dose, timing, evidence grade badge, shortDescription, and optional mechanismOfAction/longevityRelevance for new entries |
| SUPP-02 | 11-01, 11-03, 11-05 | Drug database expanded with 5 OTC/Rx drug classes; same field structure as supplements | SATISFIED | nsaids_class, aspirin_class, statins_class, levothyroxine_class, metformin_rx — all 5 present in prescription_only category with matching field structure |
| SUPP-03 | 11-02, 11-04, 11-05 | Interaction checker evaluates current supplement + medication stack with red/yellow/green severity flags | SATISFIED (with human note on grouping) | 54 interaction pairs with 4 severity levels; InteractionCheckerScreen auto-populates from AsyncStorage; results sorted by severity with color-coded badges; see SC3 human check |
| SUPP-04 | 11-02, 11-04, 11-05 | Every interaction flag includes plain-language explanation and actionable recommendation | SATISFIED | All 54 INTERACTIONS entries have non-empty `recommendation` field; `body` (plain-language explanation) + `recommendation` both rendered in expanded interaction card |

---

## Anti-Patterns Found

| File | Line | Pattern | Severity | Impact |
|------|------|---------|----------|--------|
| src/screens/InteractionCheckerScreen.tsx | 397–400 | `shadowColor: '#000'` | Info | Pre-existing style — confirmed present before Phase 11 (per 11-05 SUMMARY "pre-existing shadowColor lines only"). No Phase 11 code introduced this. |
| src/data/biomarkers.ts | 1252 | `// ── Phase 11 additions — [PHARMACIST REVIEW REQUIRED]` comment | Info | Source citation comment placed intentionally per Plan 11-02 design. Pharmacist checkpoint completed and approved (11-02-SUMMARY: "Pharmacist checkpoint completed and approved"). Not a TBD/FIXME/XXX debt marker. |

No TBD, FIXME, or XXX markers found in any Phase 11 modified file.

---

## Notable Observations

### Plan 11-01 deviation: original 8 supplements lack mechanismOfAction/longevityRelevance

NMN, NR, Fisetin, Spermidine, Quercetin, Rapamycin (rapamycin_rx), and Metformin (metformin_rx) are pre-Phase-11 entries. Plan 11-01 added `mechanismOfAction`, `longevityRelevance` fields to the interface as **optional** and populated them only on the 18 net-new entries and 4 drug classes. The 7 pre-existing named supplements do not have these fields.

In the library UI, when users expand those rows, the "How:" and "Why:" lines simply don't render (the component checks `info.mechanismOfAction ? ... : null`). The `shortDescription` (always present) serves as the one-line summary required by ROADMAP SC1. This satisfies SC1 ("one-line longevity relevance summary" = shortDescription) but is a gap relative to REQUIREMENTS.md SUPP-01 text ("each entry includes... mechanism of action, and longevity relevance summary") when interpreted as requiring those specific fields on all 8 entries.

Functional impact: Users tapping on NMN, NR, Fisetin, Spermidine, Quercetin, Rapamycin, or Metformin in the library will see dose + timing in the expanded detail, but will NOT see "How:" or "Why:" explanatory text. Only the shortDescription in the row header is visible. The Urolithin A entry (new Phase-11) shows full "How:" and "Why:" text.

### Plan 11-04 deviation: autoPopulated guard implementation

Plan 11-04 specified `useState(false)` for the autoPopulated guard, but the implementation uses `useRef(false)` and RESETS to false on every focus event. This means the checker re-reads AsyncStorage on every screen focus (not once per session). The SUMMARY documents this as intentional: "Reset on every focus so profile changes are picked up." The deduplication logic prevents duplicate items from being added. This is a behavioral improvement over the spec but differs from the "once per session" must-have.

---

## Human Verification Required

### 1. Interaction checker severity "grouping" — visual UX

**Test:** Add CBD and Warfarin to the interaction checker, then add NMN + Apigenin. Observe how the results list displays.

**Expected:** Results should be visually comprehensible as "grouped by severity" — dangerous pairs (red) appear first/separately from safe synergies (green). User can immediately distinguish high-risk flags from beneficial synergies.

**Why human:** The implementation sorts interactions high→moderate→low→beneficial and uses `Colors.danger`/`Colors.warning`/`Colors.primaryLight` for per-card badges. This is not grouped under explicit section headers (e.g., "High Risk", "Monitor Required"). Whether a sorted, color-coded flat list satisfies ROADMAP SC3 "grouped by severity" is a UX judgment that requires on-device inspection.

---

## Gaps Summary

No hard blockers found. SC1, SC2, and SC4 are verified. SC3 is uncertain on the "grouped" semantics — the functionality (sorted, color-coded, recommendation always present) exists but the visual grouping pattern (section headers vs. sorted list) requires pharmacist/user confirmation on-device.

The missing `mechanismOfAction`/`longevityRelevance` on 7 pre-existing entries is a quality gap relative to SUPP-01 wording but does not block SC1 (which only requires "one-line longevity relevance summary" = shortDescription, which all entries have).

---

_Verified: 2026-06-05_
_Verifier: Claude (gsd-verifier)_
